Autopsy report · NCT03195010

Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia

“Terminated because of slow recruitment and lack of funding support”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 6 months before it stopped.
• 4 participants enrolled.
• Results were posted on the registry 10 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Fred Hutchinson Cancer Center

Sponsor type

University, hospital or other

Conditions

Acute Biphenotypic Leukemia; Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; B-Cell Non-Hodgkin Lymphoma; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia, BCR-ABL1 Positive

Interventions

Platelet Transfusion; Platelet Transfusion

Participants

4

Sites

1

Countries

United States

Trials that died the same way

• Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease
  “terminated due to slow recruitment” (88% match in meaning)
• Seroquel in Acute Mania: Study to Investigate if Valproate Add-On Therapy is Superior to Quetiapine Monotherapy in Acutely Manic Patients
  “terminated due to very low recruitment rate (27 June 2006)” (84% match in meaning)
• IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing Surgery
  “Terminated due to lack of funding” (84% match in meaning)
• Cromoglicate in Mastocytosis
  “prematurely terminated because of low recruitment” (82% match in meaning)
• Paracetamol Versus Placebo in Conjunction With Strong Opioids for Cancer Pain
  “Funding was terminated early due to slow recruitment.” (82% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.